# clm_19A157E5E599

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: total_equity  
value: 18,952,000,000 United States dollar  
valid_from: 2021-03-31  
valid_to: 2021-06-30  
published: 2021-05-06  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_217A2416EF41  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences total equity: 18,952,000,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_19A157E5E599, https://asof.is/claim/clm_19A157E5E599, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209521000013/0000882095-21-000013-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-06  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209521000013/0000882095-21-000013-index.htm (primary, SEC EDGAR 10-Q Q1 FY2021, published 2021-05-06)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | total_equity | 18,202,000,000 United States dollar | valid 2020-12-31 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_19A157E5E599](/claim/clm_19A157E5E599.md) | [clm_1E9CDD4692C6](/claim/clm_1E9CDD4692C6.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.